Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ROAD study of redispensing unused oral anticancer drugs
NL-OMON23519Active, not recruiting
- Sponsor
- ZonMw
- Start
- Feb 2021
- Countries
- 1
01
Overview
Open-label trial in cancer, sponsored by ZonMw. Primary endpoint: Cost savings and environmental impact of redispensing program. Started Feb 2021; status: active, not recruiting.
02
Conditions
cancer
Beyond the preview
Go deeper on NL-OMON23519.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON23519.